An analysis of the CALLA study shows that ctDNA is detected an average of 5.5 months before radiographic progression.

The test is currently available in private healthcare facilities but there are hopes it may be adopted by the NHS.

Male patients with ER+ breast cancer tend to have grade 2 or 3 tumors, stage II or III disease, and progesterone receptor-positivity compared to female patients.

Decision-making forms the core of hospital patient care, involving an array of clinicians whose duties span diagnosis, ...

The proportion of patient harms associated with medical procedures, treatment, and contact with healthcare systems rose by 59 ...